Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Model No.: 863127-77-9
Brand: DM
Grade Standard: Medicine Grade
Packaging: double PE with aluminium foil bag
Productivity: 100kg/month
Transportation: Ocean,Air
Place of Origin: Hebei,China
Supply Ability: 100kg/month
Certificate: ISO9001
Port: Shanghai
Payment Type: L/C,T/T,Paypal
Incoterm: FOB,CFR,CIF
Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body.
Dasatinib, previously known as BMS-354825, Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Test items | Standards | Results |
| Appearance | White to off-white powder | off-white powder |
| Identification | IR | Conform |
| Water | 3.0~5.0% | 4.0% |
| Heavy metals | ≤20ppm | Conforms |
|
Related Substance | Single impurity<0.1% | 0.06% |
| Total Impurities<1.0% | 0.18% | |
| Purity | ≥99.0% | 99.82% |
| Residue on ignition | <0.1% | 0.05% |
Dasatinib is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective.
Product Categories : APIs And Intermediates > Dasatinib Intermediates
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now